MedPath

intrathecal hyperbaric ropivaccaine (0.75%) versus hyperbaric bupivaccaine (0.5%) in elective urological surgeries

Phase 4
Conditions
Health Condition 1: N209- Urinary calculus, unspecified
Registration Number
CTRI/2023/04/051852
Lead Sponsor
MGM medical college and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade 1,2,3 patients who undergo elective urologicalsurgeries under spinal anaesthesia

Exclusion Criteria

contraindications of spinal anaesthesia such as local infection raised intracranial tension coagulopathy valvular heart disease known allergies tp study drugs severe left systolic dysfunction ( <30%) pregnancy lactating mothers surgeries more than 3hours of duration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To comapre the efficacy and safety of hyperbaric ropivaccaine (0.75%) and hyperbaric bupivaccaine (0.5%) for spinal anaesthesia in patients undergoing elective urological surgeriesTimepoint: 1.onset of sensory block <br/ ><br>2.maximum height of sensory block <br/ ><br>3.duration of sensory block <br/ ><br>4.onset of motor block <br/ ><br>5.duration of motor block
Secondary Outcome Measures
NameTimeMethod
1. To study and compare intraoperative heart rate <br/ ><br>2. To study and compare intraoperative mean blood pressureTimepoint: Every 10 min till 1st hour after intrathecal administration of study drug and after every 15 min there after
© Copyright 2025. All Rights Reserved by MedPath